prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, SPECIMENS: A. UPPER OUTER QUADRANT LEFT BREAST. B. LEFT BREAST CANCER. C. SLN #1. D. SLN #2. E. SLN #3. SPECIMEN(S): A. UPPER OUTER QUADRANT LEFT BREAST. B. LEFT BREAST CANCER. C. SLN #1. D. SLN #2. E. SLN #3. INTRAOPERATIVE CONSULTATION DIAGNOSIS: A- upper outer quadrant left breast: Lesion 2 mm from posterior margin. B- left breast cancer: Tumor at anterior margin. TPC, TPD, TPE-sentinel lymph node #1, #2, #3: No tumor seen. Diagnoses called by Dr. to Dr. at. (C, D, E) and. I. (A,B). GROSS DESCRIPTION: A. UPPER OUTER QUADRANT LEFT BREAST. Received fresh labeled with the patient's identification and "upper outer quadrant left breast" is an oriented (single-. anterior, double-lateral) 18 g, 2.5 x 2.5 x 2 cm needle localized lumpectomy with radiograph. Ink code: Anterior-. yellow, posterior-black, medial-green, lateral-red, superior-blue, inferior-orange. Specimen is serially sectioned from. lateral to medial in to 8 slices revealing a 0.5 x 0.4 x 0.3 cm firm fibrous area with hemorrhage that is closest to the. posterior margin at 0.2 cm. Representatively submitted: A1: lateral margin, perpendicular sections. A2: slice 3, posterior superior. A3: slice 4, anterior/superior. A4: slice 4, posterior superior (mass). A5: slice 4, anterior/inferior. A6: slice 6, posterior inferior. A7: slice 5, superior (mass). A8: slice 5, inferior. A9: slice 6, inferior. A10: slice 7, superior. A11: slice 7, inferior. A12: medial margin, perpendicular sections. B. LEFT BREAST CANCER. Received fresh labeled with the patient's identification and "left breast cancer" is an oriented (single-anterior, double-. lateral) needle localized lumpectomy with radiograph. Ink code: Anterior-yellow, posterior-black, medial-green,. lateral-right, superior-blue, inferior-orange. Specimen is serially sectioned from medial to lateral into 7 slices. revealing a 1.8 x 1.5 x 1.5 cm firm tan stellate mass that is closest to the anterior margin at less than 0.1 cm. Tissue. is procured. Representatively submitted: B1-B2: medial margin, perpendicular sections. B3: slice 2, anterior/inferior. B4: slice 3, mid section. B5: slice 3, anterior/inferior. B6: slice 4, anterior/superior (mass). B7: slice 4, posterior superior. B8: slice 4, anterior/inferior. B9: slice 4, posterior inferior. B10: slice 5, anterior/superior (mass). B11: slice 5, posterior superior. B12: slice 5, anterior-inferior (mass). B13: slice 5, posterior inferior. B14: slice 6, anterior/inferior. B15: lateral margin, perpendicular sections. C. SLN #1. Received fresh labeled with the patient's identification and "SLN #1" is a 2 x 1.5 x 1 cm piece of adipose tissue. containing a 1.5-cm lymph node. It is sectioned and a touch prep is performed; lymph node is submitted entirely in. cassette C1. D. SLN #2. Received fresh labeled with the patient's identification and "SLN #2" is a 1.5 x 1 x 0.3 cm piece of adipose tissue. containing a 0.5-cm lymph node. A touch prep is performed in the lymph node is submitted entirely in cassette D1. E. SLN #3. Received fresh labeled with the patient's identification and "SLN #3" is a 2 x 2 x 1 cm piece of adipose tissue. containing a 2-cm lymph node. Specimen is sectioned, touch prep is performed, submitted entirely in cassette E1. DIAGNOSIS: A. BREAST, LEFT OUTER QUADRANT: - BREAST TISSUE. - RADIAL SCAR. - PREVIOUS BIOPSY SITE. - NO MALIGNANCY IS SEEN. B. BREAST, LEFT, EXCISION: - INVASIVE DUCTAL CARCINOMA, SBR GRADE II, MEASURING 0.5-CM. - DUCTAL CARCINOMA-IN-SITL NUCLEAR GRADE 2/3, SOLID TYPE. - LYMPHOVASCULAR INVASION IS SEEN. - TUMOR IS VERY CLOSE TO THE ANTERIOR MARGIN (<1 MM). PREVIOUS BIOPSY SITE CHANGES. SEE SYNOPTIC REPORT. C. LYMPH NODE, SENTINEL #1, LEFT AXILLA, EXCISION: - ONE REACTIVE LYMPH NODE. - NEGATIVE FOR METASTATIC CARCINOMA (0/1). D. LYMPH NODE, SENTINEL #1, LEFT AXILLA, EXCISION: - ONE REACTIVE LYMPH NODE. - NEGATIVE FOR METASTATIC CARCINOMA (0/1). E. LYMPH NODE, SENTINEL #1, LEFT AXILLA, EXCISION: - ONE REACTIVE LYMPH NODE. - NEGATIVE FOR METASTATIC CARCINOMA (0/1). SYNOPTIC REPORT - BREAST. Specimens Involved. Specimens: B: LEFT BREAST CANCER. Specimen Type: Excision. Needle Localization: Yes For mass. Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 1.8cm. Additional dimensions: 1.5cm x 1.5cm. Tumor Site: Upper outer quadrant. Margins: Negative. Distance from closest margin: Less than 0.1cm. anterior. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 1. Modified Scarff Bloom Richardson Grade: 2. /ascular/Lymphatic Invasion: Present. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/3. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 5%. DCIS Type: Solid. DCIS Location: Associated with invasive tumor. Nuclear grade: Low. Necrosis: Absent. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative. Performed on Case: outside core biopsy. Pathological staging (pTN): pT 1c N 0. CLINICAL HISTORY: 1) upper outer quadrant radial scar by core biopsy. 2) 12 o'clock invasive cancer. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. ADDENDUM: ONCOTYPE DX BREAST CANCER ASSAY. RESULTS: Recurrence Score: 7. CLINICAL EXPERIENCE: Patients with a recurrence score of: 7 in the clinical validation study had an average. rate of Distant Recurrence at 10 years of 6%. ER Score: 11.4 Positive. PR Score: 9.7 Positive. Her2 Score: 8.9 Negative. Interpretation: ER Negative < 6.5 Positive >= 6.5. PR Negative < 5.5 Positive >= 5.5. Her2 Negative <10.7 Positive >=11.5 Equivocal = 10.7 - 11.4. See separate. report for further information. The maximum tumor size from the gross description and all slides of the tumor is 1.8cm,. The smaller measurement 0.5cm in the diagnosis refers to a partial tumor measurement. from a representative slide of the tumor. The maximum tumor size 1.8cm is the total final measurement used for the cancer staging. in this case. The stage remains unchanged pT1c pNO. Case discussed with Dr. Microscopic/Diagnostic Dictation: Pathologist. Final Review: Pathologist. Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist,.

expanded version (tokens=2295) : 
 Here is a summary of the information from the breast pathology report:

- Histological classification: invasive ductal carcinoma (IDC) and ductal carcinoma in situ (DCIS), subtype LumA
- Necrosis: absent
- Tumor infiltrating lymphocytes: not mentioned
- Histological grade: SBR grade II for IDC, nuclear grade 2/3 for DCIS
- Nuclear grade: 2 for IDC, variable 2/3 for DCIS
- Lymphovascular invasion: present
- Calcification: not mentioned
- Receptor status: ER positive, PR positive, HER2 negative
- IHC and other ancillary testing results: Oncotype DX breast cancer assay resulted in a recurrence score of 7, ER score of 11.4, PR score of 9.7, and HER2 score of 8.9.

Additional details:

- A biopsy of the upper outer quadrant left breast showed a radial scar but no malignancy.
- The left breast cancer was a 1.8cm stellate mass closest to the anterior margin at less than 0.1cm. It had both invasive and in situ components.
- Three sentinel lymph nodes were negative for metastatic carcinoma.
- The final diagnosis was IDC and DCIS, LumA subtype, with lymphovascular invasion. The Oncotype DX assay had a low recurrence score of 7, and the tumor was ER and PR positive but HER2 negative. The

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2425) : 
 The pathology report indicates LumA subtype IDC and DCIS with lymphovascular invasion. Necrosis or tumor-infiltrating lymphocytes were not mentioned, and the Oncotype DX assay resulted in a low recurrence score of 7, ER/PR positive but HER2 negative. The tumor was close to the anterior margin and measured 1.8 cm. Three sentinel lymph nodes were negative for metastatic carcinoma.

